Department of General Surgery, China-Japan Friendship Hospital, Beijing, China.
Oncol Res Treat. 2021;44(5):261-268. doi: 10.1159/000508431. Epub 2021 Apr 28.
We aimed to compare the oncological outcomes of laparoscopy and open resection for patients with rectal cancer following neoadjuvant chemoradiotherapy (NCRT).
We searched the publications that compared the efficacy of laparoscopic surgery and open thoracotomy in treatment outcomes of rectal cancer after NCRT. All trials analyzed the summary hazard ratios of the endpoints of interest, including survival and individual postoperative complications.
Totally, 10 trials met our inclusion criteria. The pooled analysis of 3-year disease-free survival (OR 1.39, 95% CI 0.93-2.06; p = 0.11) and 3-year overall survival (OR 1.01, 95% CI 0.70-1.45; p = 0.97) showed that laparoscopic surgery did not achieve beneficial effects compared with open thoracotomy. The pooled result of duration of surgery indicated that laparoscopic surgery was associated with a trend for longer surgery time (SMD 27.53, 95% CI 1.34-53.72; p = 0.04), shorter hospital stay (SMD -1.64, 95% CI -2.70 to -0.58; p = 0.002), more postoperative complications (OR 0.77, 95% CI 0.60-0.99; p = 0.04), and decreased blood loss (SMD -49.87, 95% CI -80.61 to -19.14; p = 0.001). However, the number of removed lymph nodes, positive circumferential resection margin, as well as complications after surgery showed significant differences between the 2 groups.
We focused on current evidence and reviewed the studies indicating that similar oncological outcomes were associated with laparoscopic surgery following NCRT for patients with locally advanced lower rectal cancer in comparison with open surgery.
本研究旨在比较新辅助放化疗(NCRT)后接受腹腔镜和开放直肠切除术的直肠癌患者的肿瘤学结局。
我们检索了比较新辅助放化疗后腹腔镜手术与开胸手术治疗直肠癌疗效的文献。所有试验均分析了感兴趣终点的汇总危害比,包括生存和个体术后并发症。
共有 10 项试验符合纳入标准。3 年无病生存率(OR 1.39,95%CI 0.93-2.06;p=0.11)和 3 年总生存率(OR 1.01,95%CI 0.70-1.45;p=0.97)的合并分析表明,与开胸手术相比,腹腔镜手术并未带来有益的效果。手术时间的合并结果表明,腹腔镜手术与手术时间较长相关(SMD 27.53,95%CI 1.34-53.72;p=0.04),住院时间较短(SMD-1.64,95%CI-2.70 至-0.58;p=0.002),术后并发症更多(OR 0.77,95%CI 0.60-0.99;p=0.04),出血量减少(SMD-49.87,95%CI-80.61 至-19.14;p=0.001)。然而,两组之间切除的淋巴结数量、阳性环周切缘以及术后并发症存在显著差异。
我们关注现有证据,并回顾了表明在新辅助放化疗后,与开放手术相比,腹腔镜手术治疗局部晚期低位直肠癌患者具有相似的肿瘤学结局的研究。